Drug Approval | August 22, 2023
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Subscribe To Our Newsletter & Stay Updated
